SMMT Historical PE Ratio image   This SMMT PE ratio history page last updated 8/15/2022
SMMT Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q2 2022
8/11/2022
1.09-0.17-0.68NA
Q1 2022
5/11/2022
1.02-0.22-0.88NA
Q4 2021
3/17/2022
3.13-0.28-1.12NA
Q3 2021
11/15/2021
5.20-0.20-0.80NA
Q2 2021
8/11/2021
7.78-0.27-1.08NA
Q1 2021
5/17/2021
6.85-0.21-0.84NA
Q4 2020
3/17/2021
6.16-0.18-0.72NA
Q3 2020
11/16/2020
4.91-0.26-1.04NA
Q2 2020
9/29/2020
3.50-0.23-0.92NA
Q1 2020
6/2/2020
3.75-0.02-0.08NA
Q4 2019
4/30/2020
3.75-0.05-0.20NA
Q3 2019
12/17/2019
1.48-0.05-0.20NA
Q2 2019
10/11/2019
1.65-0.04-0.16NA
Q1 2019
6/12/2019
1.42-0.04-0.16NA
Q4 2018
3/27/2019
1.82-0.08-0.32NA
Q3 2018
12/11/2018
1.27-0.13-0.52NA
Q2 2018
9/20/2018
2.320.421.681.4
Q1 2018
6/5/2018
13.26-0.11-0.44NA
Q4 2017
4/11/2018
13.37-0.23-0.92NA
Q3 2017
12/6/2017
11.450.000.00NA
Q2 2017
8/31/2017
12.870.220.8814.6
Q1 2017
6/14/2017
10.67-0.10-0.40NA
Q4 2016
3/29/2017
13.28-0.10-0.40NA
Q3 2016
12/15/2016
8.50-0.09-0.36NA
Q2 2016
9/8/2016
6.21-0.13-0.52NA
Q1 2016
5/10/2016
8.53-0.11-0.44NA
Q4 2015
1/15/2016
9.00-0.11-0.44NA
Q3 2015
12/17/2015
10.96-0.12-0.48NA
Q2 2015
8/27/2015
12.17-0.11-0.44NA
SMMT PE History Chart
PeriodPriceGAAPTTMPE
Q2 2022
8/11/2022
1.09-0.17-0.87NA
Q1 2022
5/11/2022
1.02-0.22-0.70NA
Q4 2021
3/17/2022
3.13-0.28-0.75NA
Q3 2021
11/15/2021
5.20-0.20-0.68NA
Q2 2021
8/11/2021
7.78-0.27-0.92NA
Q1 2021
5/17/2021
6.85-0.21-0.88NA
Q4 2020
3/17/2021
6.16-0.18-0.69NA
Q3 2020
11/16/2020
4.91-0.26-0.56NA
Q2 2020
9/29/2020
3.50-0.23-0.35NA
Q1 2020
6/2/2020
3.75-0.02-0.16NA
Q4 2019
4/30/2020
3.75-0.05-0.18NA
Q3 2019
12/17/2019
1.48-0.05-0.21NA
Q2 2019
10/11/2019
1.65-0.04-0.29NA
Q1 2019
6/12/2019
1.42-0.040.178.4
Q4 2018
3/27/2019
1.82-0.080.1018.2
Q3 2018
12/11/2018
1.27-0.13-0.05NA
Q2 2018
9/20/2018
2.320.420.0829.0
Q1 2018
6/5/2018
13.26-0.11-0.12NA
Q4 2017
4/11/2018
13.37-0.23-0.11NA
Q3 2017
12/6/2017
11.450.000.02>500
Q2 2017
8/31/2017
12.870.22-0.07NA
Q1 2017
6/14/2017
10.67-0.10-0.42NA
Q4 2016
3/29/2017
13.28-0.10-0.43NA
Q3 2016
12/15/2016
8.50-0.09-0.44NA
Q2 2016
9/8/2016
6.21-0.13-0.47NA
Q1 2016
5/10/2016
8.53-0.11-0.45NA
Q4 2015
1/15/2016
9.00-0.11NANA
Q3 2015
12/17/2015
10.96-0.12NANA
Q2 2015
8/27/2015
12.17-0.11NANA
Quotes delayed 20 minutes

Email EnvelopeFree SMMT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Summit Therapeutics (SMMT) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

SMTI PE Ratio History
SNDA PE Ratio History
SNDX PE Ratio History
SNGX PE Ratio History
SNOA PE Ratio History
SNSE PE Ratio History
SOLY PE Ratio History
SONN PE Ratio History
SPNE PE Ratio History
SPPI PE Ratio History
How should the SMMT historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Summit Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this SMMT Historical PE Ratio page.

What is the average historical PE for SMMT based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The SMMT historical PE ratio using the annualized quarterly earnings method works out to 8.0.

What is the average historical PE for SMMT based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The SMMT historical PE ratio using the TTM earnings method works out to 18.5.

On this page we presented the SMMT Historical PE Ratio information for Summit Therapeutics' stock. The average SMMT historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 8.0. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average SMMT historical PE based on this TTM earnings result method is 18.5. Note: any PE calculations resulting in a value exceeding 500 were discarded as not meaningful. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this SMMT historical PE result, against the recent PE: when this page was posted on 8/12/2022, the most recent closing price for SMMT had been 1.06, and the most recent quarterly earnings result, annualized, was 1.68. Meanwhile, the most recent TTM earnings summed to 0.17. From these numbers, we calculate the recent SMMT PE on 8/12/2022 based on annualized quarterly EPS was 0.6. Based on SMMT's history, that recent PE is low relative to the historical average, with the recent PE 92.5% lower than the historical average PE across our data set for Summit Therapeutics. Looking at the recent SMMT PE on 8/12/2022 based on TTM EPS, we calculate the ratio at 6.2. Based on SMMT's history, that recent PE is low relative to the historical average, with the recent PE 66.5% lower than the average PE across our Summit Therapeutics data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on SMMT or any other given stock, valuation analysis for SMMT can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Summit Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for SMMT. Thanks for visiting, and the next time you need to research SMMT Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: YRIV YTD Return, PATK Options Chain, HQH Average Annual Return.

 

SMMT Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.